NCT06575452View on ClinicalTrials.gov

Using the Epitranscriptome to Diagnose and Treat Gliomas

NANot yet recruitingINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

April 30, 2028

Conditions
Glioma
Interventions
DIAGNOSTIC_TEST

Blood, urine and tumoral tissue samples

Blood, urine and tumoral tissue samples

DIAGNOSTIC_TEST

Tumoral tissue samples

tumoral tissue samples

Trial Locations (2)

34090

CHU Montpellier - Hôpital St Eloi, Montpellier

34298

Insitut Régional du Cancer de Montpellier, Montpellier

All Listed Sponsors
collaborator

National Cancer Institute, France

OTHER_GOV

lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER

NCT06575452 - Using the Epitranscriptome to Diagnose and Treat Gliomas | Biotech Hunter | Biotech Hunter